Literature DB >> 27262997

Obesity-Induced Hypertension: Brain Signaling Pathways.

Jussara M do Carmo1, Alexandre A da Silva2,3, Zhen Wang2, Taolin Fang2, Nicola Aberdein2, Cecilia E P de Lara Rodriguez2, John E Hall2.   

Abstract

Obesity greatly increases the risk for cardiovascular, metabolic, and renal diseases and is one of the most significant and preventable causes of increased blood pressure (BP) in patients with essential hypertension. This review highlights recent advances in our understanding of central nervous system (CNS) signaling pathways that contribute to the etiology and pathogenesis of obesity-induced hypertension. We discuss the role of excess adiposity and activation of the brain leptin-melanocortin system in causing increased sympathetic activity in obesity. In addition, we highlight other potential brain mechanisms by which increased weight gain modulates metabolic and cardiovascular functions. Unraveling the CNS mechanisms responsible for increased sympathetic activation and hypertension and how circulating hormones activate brain signaling pathways to control BP offer potentially important therapeutic targets for obesity and hypertension.

Entities:  

Keywords:  Blood pressure; Leptin; Melanocortins; Metabolism; Sympathetic nervous system

Mesh:

Year:  2016        PMID: 27262997      PMCID: PMC5448788          DOI: 10.1007/s11906-016-0658-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  84 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 2.  The brain melanocortin system, sympathetic control, and obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Zhen Wang; John E Hall
Journal:  Physiology (Bethesda)       Date:  2014-05

3.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

4.  Adiponectin replenishment ameliorates obesity-related hypertension.

Authors:  Koji Ohashi; Shinji Kihara; Noriyuki Ouchi; Masahiro Kumada; Koichi Fujita; Aki Hiuge; Toshiyuki Hibuse; Miwa Ryo; Hitoshi Nishizawa; Norikazu Maeda; Kazuhisa Maeda; Rei Shibata; Kenneth Walsh; Tohru Funahashi; Iichiro Shimomura
Journal:  Hypertension       Date:  2006-05-01       Impact factor: 10.190

5.  Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation.

Authors:  Qian Gao; Michael J Wolfgang; Susanne Neschen; Katsutaro Morino; Tamas L Horvath; Gerald I Shulman; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

6.  Sustained activation of the central baroreceptor pathway in obesity hypertension.

Authors:  Thomas E Lohmeier; Susan Warren; J Thomas Cunningham
Journal:  Hypertension       Date:  2003-05-27       Impact factor: 10.190

7.  Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension.

Authors:  Ai Nagae; Megumi Fujita; Hiroo Kawarazaki; Hiromitsu Matsui; Katsuyuki Ando; Toshiro Fujita
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

8.  Chronic central nervous system MC3/4R blockade attenuates hypertension induced by nitric oxide synthase inhibition but not by angiotensin II infusion.

Authors:  Alexandre A da Silva; Jussara M do Carmo; John H Dubinion; Mirian Bassi; Kasra Mokhtarpouriani; Shereen M Hamza; John E Hall
Journal:  Hypertension       Date:  2014-10-06       Impact factor: 10.190

9.  Sympathetic renal innervation and resistant hypertension.

Authors:  Vito M Campese; Elaine Ku; Jeanie Park
Journal:  Int J Hypertens       Date:  2011-01-20       Impact factor: 2.420

Review 10.  Hypothalamic signaling mechanisms in hypertension.

Authors:  Casey Y Carmichael; Richard D Wainford
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

View more
  17 in total

Review 1.  Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.

Authors:  Priya Balasubramanian; Delton Hall; Madhan Subramanian
Journal:  Geroscience       Date:  2018-12-05       Impact factor: 7.713

Review 2.  Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation.

Authors:  Alan J Mouton; Xuan Li; Michael E Hall; John E Hall
Journal:  Circ Res       Date:  2020-03-12       Impact factor: 17.367

Review 3.  Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Zhen Wang; John E Hall
Journal:  Curr Hypertens Rep       Date:  2019-04-26       Impact factor: 5.369

Review 4.  Sensory signals mediating high blood pressure via sympathetic activation: role of adipose afferent reflex.

Authors:  Carolina Dalmasso; Jacqueline R Leachman; Jeffrey L Osborn; Analia S Loria
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-12-23       Impact factor: 3.619

Review 5.  Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance.

Authors:  Leon J DeLalio; Alan F Sved; Sean D Stocker
Journal:  Can J Cardiol       Date:  2020-03-06       Impact factor: 5.223

Review 6.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 7.  Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.

Authors:  Rohan Samson; Andrea Qi; Abhishek Jaiswal; Thierry H Le Jemtel; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

8.  Obesity-induced sympathoexcitation is associated with Nrf2 dysfunction in the rostral ventrolateral medulla.

Authors:  Priya Balasubramanian; Ninitha Asirvatham-Jeyaraj; Raisa Monteiro; Mahesh Kumar Sivasubramanian; Delton Hall; Madhan Subramanian
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-12-11       Impact factor: 3.619

Review 9.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

10.  Early life and adolescent arsenic exposure from drinking water and blood pressure in adolescence.

Authors:  Yu Chen; Fen Wu; Xinhua Liu; Faruque Parvez; Nancy J LoIacono; Elizabeth A Gibson; Marianthi-Anna Kioumourtzoglou; Diane Levy; Hasan Shahriar; Mohammed Nasir Uddin; Taruqul Islam; Angela Lomax; Roheeni Saxena; Tiffany Sanchez; David Santiago; Tyler Ellis; Habibul Ahsan; Gail A Wasserman; Joseph H Graziano
Journal:  Environ Res       Date:  2019-08-20       Impact factor: 8.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.